At MASURATION, we are revolutionizing computer-assisted surgery with our cutting-edge surgical navigation technologies. Our innovative solutions redefine the standards of accuracy, precision, and reliability, empowering surgeons to perform complex procedures with unparalleled confidence from head to toe. As we stand on the brink of transformative growth, we invite visionary investors to join us on our journey to redefine surgical excellence.
Developed through the application of mathematically validated, clinically tested, and methodically established criteria to guarantee adherence to the highest standards of reliability in the operating room.
Noctopus: A novel device and method to perform the surgical navigation with unparalleled accuracy, precision and reliability. This technology improves outcomes for patients undergoing complex minimal invasive surgeries such as neurosurgery, ENT, spine, orthopedics, percutaneous biopsy, interventional radiology, and numerous other surgical interventions.
Nocvirtus: A novel method to perform surgical navigation. (announcement coming soon)
The global surgical navigation market is projected to reach $8 billion by 2030, driven by advancements in minimally invasive surgeries and an increasing demand for precision in surgical procedures.
We are seeking strategic investments that will support our growth, expand our research and development efforts, and accelerate the rollout of our revolutionary surgical navigation technologies. Together, we can transform the landscape of computer-assisted surgery and improve patient care on a global scale.
To explore investment opportunities and learn more about MASURATION, please reach out using CONTACT form or email.
Invest in MASURATION and be part of a future where surgical navigation technology elevates the standards of medical care.